LivaNova — CureCurrent

How to interpret these research links

Connected source records

The exact organization name LivaNova appears in 17 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials17

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

17 shown

ANTHEM-HFrEF Pivotal StudyNCT03425422 · lead sponsor · 2018-05-01

Clinical Evaluation of LEft VEntricular Auto Threshold Algorithm (LEVEA)NCT03014180 · lead sponsor · 2017-02-16

VAgal Nerve Stimulation: safeGUARDing Heart Failure PatientsNCT02113033 · lead sponsor · 2014-10-07

Left Ventricular Pacing Vectors Effectiveness to Narrow Phrenic Nerve StimulationNCT03127202 · lead sponsor · 2012-11-01

Clinical Evaluation Of The SonR Atrial Lead In Paradym RF DeviceNCT01169272 · lead sponsor · 2010-10-01

Clinical Evaluation Of The PARADYM RF DeviceNCT01193634 · lead sponsor · 2010-10-01

Clinical Status Monitoring in Implantable Cardiac Defibrillator (ICD) Patients by Physiological Diagnosis (PhD) FunctionNCT01170624 · lead sponsor · 2009-09-01

Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT DeviceNCT02167789 · lead sponsor · 2009-09-01

Echocardiography and Peak Endocardial Acceleration (PEA) Measurements in Cardiac Resynchronization Therapy (CRT)NCT01066078 · lead sponsor · 2007-10-01

Clinical Evaluation on Advanced ResynchronizationNCT00658203 · lead sponsor · 2005-11-01

Sleep Apnea, Arrhythmias and Cardiac Reverse Remodeling in Heart Failure PatientsNCT02870647 · lead sponsor

Pilot Study to Evaluate the Somnotouch Device to Quantify Spontaneous Baroreflex SensitivityNCT02650232 · collaborator · 2015-12-01

Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients?NCT01437371 · collaborator · 2011-08-01

Acute Optimization of Cardiac Resynchronization Therapy (CRT)Using Echocardiography and SonRNCT01293526 · collaborator · 2011-02-01

Atrio-Ventricular (AV) Delay Optimization Using Echocardiography Versus the SonR SignalNCT01287234 · collaborator · 2011-01-01

Evaluation of a Diagnostic Feature in a Cardiac Resynchronization Therapy (CRT) DeviceNCT00957541 · collaborator · 2009-09-01

European Cardiac Resynchronisation Therapy SurveyNCT01185392 · collaborator · 2008-11-01

Drugs studied in this sponsor's trials

0 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing LivaNova as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

No mapped drug interventions are published for this sponsor's trials. This does not mean the studies contain no drug interventions: some registry names have not been mapped to RxNorm.

Sponsor roles

lead sponsor11

collaborator6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.